Zoll Medical 2Q profit rises
Zoll Medical Corp., a maker of cardiac defibrillators and pacemakers for emergency resuscitation, said Friday its second-quarter profit surged more than thirteenfold, aided by higher revenue and lower operating expenses.
For the quarter ended April 2, Zoll reported net income of $2.08 million, or 21 cents per share, versus a prior-year profit of $159,000, or 2 cents per share. Revenue rose 8 percent to $56.8 million from $52.5 million in the year earlier period.
Wall Street had forecast a profit of 17 cents per share, the average estimate of seven analysts surveyed by Thomson Financial, on sales of $57.1 million.
Zoll ascribed the revenue rise to new products in North America, which offset weaker-than-expected sales growth in the international market.
The company forecast stronger performance in this year's second half, spurred by new products. (AP)
